DNA methylation in the immune system

Clinical Immunology

Volumn 109, Issue 1, 2003, Pages 2-5

  Teitell, Michael ^a   Richardson, Bruce ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; DNA METHYLTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ACUTE GRANULOCYTIC LEUKEMIA; AGING; AUTOIMMUNITY; CANCER SURVIVAL; CELL FATE; CHROMATIN; CLINICAL TRIAL; DEMETHYLATION; DNA METHYLATION; DNA REPLICATION; DNA SEQUENCE; DRUG EFFICACY; DRUG SAFETY; EUKARYOTE; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENCE; LYMPHOMA; MYELODYSPLASTIC SYNDROME; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; SOMATIC CELL; T LYMPHOCYTE; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; X CHROMOSOME;

EID: 0142216237     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00224-9     Document Type: Article

References (39)

1. Jenuwein T., Allis C.D. Translating the histone code. Science. 293:2001;1074-1080.
2. Jones P.A., Takai D. The role of DNA methylation in mammalian epigenetics. Science. 293:2001;1068-1070.
3. Tamaru H., Selker E.U. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature. 414:2001;277-283.
4. Jackson J.P., Lindroth A.M., Cao X., Jacobsen S.E. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature. 416:2002;556-560.
5. Lock L.F., Takagi N., Martin G.R. Methylation of the Hprt gene on the inactive X occurs after chromosome inactivation. Cell. 48:1987;39-46.
6. Heard E., Rougeulle C., Arnaud D., Avner P., Allis C.D., Spector D.L. Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell. 107:2001;727-738.
7. Soppe W.J., Jasencakova Z., Houben A., Kakutani T., Meister A., Huang M.S., Jacobsen S.E., Schubert I., Fransz P.F. DNA methylation controls histone H3 lysine 9 methylation and heterochromatin assembly in Arabidopsis. EMBO J. 21:2002;6549-6559.
8. Rountree M.R., Bachman K.E., Baylin S.B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25:2000;269-277.
9. Hochkiss R.D. The quantitative separation of purine, pyrimidines and nucleoside by paper chromatography. J. Biol. Chem. 168:1948;315-332.
10. Sinsheimer R.L. The action of pancreatic deoxyribonuclease. J Biol. Chem. 215:1955;579-583.
11. Gruenbaum Y., Stein R., Cedar H., Razin A. Methylation of CpG sequences in eukaryotic DNA. FEBS Lett. 124:1981;67-71.
12. Ramsahoye B.H., Biniszkiewicz D., Lyko F., Clark V., Bird A.P., Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. USA. 97:2000;5237-5242.
13. Malone C.S., Miner M.D., Doerr J.R., Jackson J.P., Jacobsen S.E., Wall R., Teitell M. CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing. Proc. Natl. Acad. Sci. USA. 98:2001;10404-10409.
14. Agirre X., Vizmanos J.L., Calasanz M.J., Garcia-Delgado M., Larrayoz M.J., Novo F.J. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients. Oncogene. 22:2003;1070-1072.
15. Gardiner-Garden M., Frommer M. CpG islands in vertebrate genomes. J. Mol. Biol. 196:1987;261-282.
16. Takai D., Jones P.A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. USA. 99:2002;3740-3745.
17. Mayer-Jung C., Moras D., Timsit Y. Effect of cytosine methylation on DNA-DNA recognition at CpG steps. J. Mol. Biol. 270:1997;328-335.
18. Mayer-Jung C., Moras D., Timsit Y. Hydration and recognition of methylated CpG steps in DNA. EMBO J. 17:1998;2709-2718.
19. Ohki I., Shimotake N., Fujita N., Jee J., Ikegami T., Nakao M., Shirakawa M. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell. 105:2001;487-497.
20. Bestor T., Laudano A., Mattaliano R., Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases, J. Mol. Biol. 203:1988;971-983.
21. Okano M., Xie S., Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19:1998;219-220.
22. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9:2000;2395-2402.
23. Bruniquel D., Schwartz R.H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 4:2003;235-240.
24. Xu G.L., Bestor T.H., Bourc'his D., Hsieh C.L., Tommerup N., Bugge M., Hulten M., Qu X., Russo J.J., Viegas-Pequignot E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature. 402:1999;187-191.
25. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science. 300:2003;489-492.
26. Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 300:2003;455.
27. Yancopoulos G.D., Alt F.W. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell. 40:1985;271-281.
28. Krangel M.S. Gene segment selection in V(D)J recombination accessibility and beyond . Nat. Immunol. 4:2003;624-630.
29. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science. 293:2001;1089-1093.
30. Ambinder R.F., Robertson K.D., Tao Q. DNA methylation and the Epstein-Barr virus. Semin. Cancer Biol. 9:1999;369-375.
31. Paulson E.J., Speck S.H. Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J. Virol. 73:1999;9959-9968.
32. Tierney R.J., Kirby H.E., Nagra J.K., Desmond J., Bell A.I., Rickinson A.B. Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation. J. Virol. 74:2000;10468-10479.
33. Yamamoto S., Yamamoto T., Shimada S., Kuramoto E., Yano O., Kataoka T., Tokunaga T. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol. Immunol. 36:1992;983-997.
34. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
35. French S.W., Dawson D.W., Miner M.D., Doerr J.R., Malone C.S., Wall R., Teitell M.A. DNA methylation profiling a new tool for evaluating hematologic malignancies . Clin. Immunol. 103:2002;217-230.
36. Esteller M., Corn P.G., Baylin S.B., Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61:2001;3225-3229.
37. Paz M.F., Fraga M.F., Avila S., Guo M., Pollan M., Herman J.G., Esteller M. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63:2003;1114-1121.
38. Silverman L.R., Demakos E.P., Peterson B.L., Kornblith A.B., Holland J.C., Odchimar-Reissig R., Stone R.M., Nelson D., Powell B.L., DeCastro C.M., Ellerton J., Larson R.A., Schiffer C.A., Holland J.F. Randomized controlled trial of azacytidine in patients with the myelodysplastic syndrome a study of the cancer and leukemia group B . J. Clin. Oncol. 20:2002;2429-2440.
39. Kornblith A.B., Herndon J.E. 2nd, Silverman L.R., Demakos E.P., Odchimar-Reissig R., Holland J.F., Powell B.L., DeCastro C., Ellerton J., Larson R.A., Schiffer C.A., Holland J.C. Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial a Cancer and Leukemia Group B study . J. Clin. Oncol. 20:2002;2441-2452.